Neurocrine Biosciences Inc at Jefferies London Healthcare Conference (Virtual) Transcript
Good morning, and good afternoon, depending on where you are. My name is Kelly Shi, one of the biotech analyst at the Jefferies. Thank you for attending our London Healthcare Conference. We are very pleased to have Neurocrine Management team for this session. From the [Neurocrine] are Mr. Kevin Gorman, Chief Executive Officer; Mr. Matthew Abernethy, Chief Financial Officer; and Mr. Kyle Gano, Chief BD and Strategy Officer. We will start out with the opening remarks by Kevin and followed by a fireside chat and the Q&A at the end. Kevin, welcome.
Thank you, Kelly, and it's good to be here in person for our first healthcare conference. I apologize for my voice. I've been getting over a cold. Yes, it's a cold that I have.
Before I start out, I would like to take this opportunity to direct people to our latest SEC filings because we will be making forward-looking statements here.
Neurocrine is a San Diego-based
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |